Worldwide Strategies (WWSG) 10-K 26 Nov 14 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Jul. 31, 2013	Oct. 31, 2014	Jan. 31, 2013
Document And Entity Information	'	'	'
Entity Registrant Name	'WORLDWIDE STRATEGIES INC	'	'
Entity Central Index Key	'0001342792	'	'
Trading Symbol	'wwsg	'	'
Entity Current Reporting Status	'No	'	'
Entity Voluntary Filers	'No	'	'
Current Fiscal Year End Date	'--07-31	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Public Float	'	'	$241,744
Entity Common Stock, Shares Outstanding	'	19,830,673	'
Document Type	'10-K	'	'
Document Period End Date	31-Jul-13	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Amendment Flag	'false	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'

Consolidated_Condensed_Balance

Consolidated Condensed Balance Sheets (USD $)	Jul. 31, 2013	Jul. 31, 2012
Current Assets:	'	'
Cash	$3,537	$4,709	[1]
Total current assets	3,537	4,709	[1]
Office equipment, net of accumulated depreciation of $22,623	0	0	[1]
Deposits	150	150	[1]
Total assets	3,687	4,859	[1]
Accounts and notes payable:	'	'
Accounts payable	84,846	80,464	[1]
Accounts payable, related party	3,900	3,900	[1]
Accrued compensation, related party	0	410,625	[1]
Accrued liabilities	26,503	12,829	[1]
Accrued liabilities, related party	4,723	102,841	[1]
Notes payable, related party, net of unamortized discount of $45,822 and $419, respectively	76,445	73,755	[1]
Notes payable, net of unamortized discount of $8,644 and $1,592, respectively	135,300	95,395	[1]
Total current liabilities	331,717	779,809	[1]
Shareholders' deficit (Note 6):	'	'
Preferred stock, $.001 par value; 25,000,000 shares authorized, 1,491,743 shares issued and outstanding	1,492	1,492	[1]
Common stock, $.001 par value, 33,333,333 shares authorized 18,859,005 and 16,870,234 shares issued and outstanding respectively.	18,860	16,871	[1]
Stock Payable	54,000	55,500	[1]
Additional paid-in capital	7,575,567	6,896,455	[1]
Accumulated deficit	-7,977,949	-7,745,268	[1]
Total shareholders' deficit	-328,030	-774,950	[1]
Total liabilities and shareholders' deficit	$3,687	$4,859	[1]
[1]	Restated

Consolidated_Condensed_Balance1

Consolidated Condensed Balance Sheets (Parenthetical) (USD $)	Jul. 31, 2013	Jul. 31, 2012
Statement of Financial Position [Abstract]	'	'
Unamortized discount, related party note	$45,822	$419	[1]
Unamortized discount, note	$8,644	$1,592	[1]
Preferred stock, par value (in dollars per share)	$0.00	$0.00	[1]
Preferred stock, shares authorized	25,000,000	25,000,000	[1]
Preferred stock, shares issued	1,491,743	1,491,743	[1]
Preferred stock, shares outstanding	1,491,743	1,491,743	[1]
Common stock, par value (in dollars per share)	$0.00	$0.00	[1]
Common stock, shares authorized	33,333,333	33,333,333	[1]
Common stock, shares issued	18,859,005	16,870,234	[1]
Common stock, shares Outstanding	18,859,005	16,870,234	[1]
[1]	Restated

Consolidated_Condensed_Stateme

Consolidated Condensed Statement of Operations (USD $)	12 Months Ended
	Jul. 31, 2013	Jul. 31, 2012
Income Statement [Abstract]	'	'
Sales	$0	$0	[1]
Cost of sales	0	0	[1]
Gross Profit, Total	0	0	[1]
Operating expenses:	'	'
Professional and consulting fees	138,156	206,883	[1]
Travel	12,566	22,010	[1]
Other general and administrative expenses	3,784	4,192	[1]
Total operating expenses	154,506	233,085	[1]
Loss from operations	-154,506	-233,085	[1]
Other expense:	'	'
Interest expense	-78,175	-114,687	[1]
Loss before income taxes	-232,681	-347,772	[1]
Income tax provision	0	0	[1]
Net loss	($232,681)	($347,772)	[1]
Basic and diluted loss per share	($0.01)	($0.01)	[1]
Basic and diluted weighted average common shares outstanding	27,487,506	24,985,016	[1]
[1]	Restated

Consolidated_Condensed_Stateme1

Consolidated Condensed Statement of Changes in Shareholders Deficit (USD $)	Preferred Stock	Common Stock	Common Stock Subscriptions Receivables	Stock Payable	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning Balance, Amount at Jul. 31, 2011	$1,492	$14,242	'	'	$6,709,824	($7,397,496)	($671,938)
Beginning Balance, Shares at Jul. 31, 2011	1,491,743	14,241,234	'	'	'	'	'
Common stock issued in exchange for interest, related party, Share	'	1,395,000	'	'	'	'	'
Common stock issued in exchange for interest, related party, Amount	'	1,395	'	1,500	95,005	'	97,900
Common stock issued in exchange for board member services, Shares	'	300,000	'	'	'	'	'
Common stock issued in exchange for board member services, Amount	'	300	'	54,000	35,700	'	90,000
Common stock issued in exchange for CFO compensation, Shares	'	300,000	'	'	'	'	'
Common stock issued in exchange for CFO compensation, Amount	'	300	'	'	13,200	'	13,500
Common stock issued for consulting services, Shares	'	634,000	'	'	'	'	'
Common stock issued for consulting services, Amount	'	634	'	'	24,726	'	25,360
Common stock options issued in exchange for CFO Compensation (Nov 2011)	'	'	'	'	6,000	'	6,000
Common stock options issued in exchange for CFO Compensation (Mar 2012)	'	'	'	'	6,000	'	6,000
Beneficial conversion feature	'	'	'	'	6,000	'	6,000
Net loss	'	'	'	'	'	-347,772	-347,772	[1]
Ending Balance, Amount at Jul. 31, 2012	1,492	16,871	'	55,500	6,896,455	-7,745,268	-774,950	[1]
Ending Balance, Shares at Jul. 31, 2012	1,491,743	16,870,234	'	'	'	'	'
Common stock issued in exchange for interest, related party, Share	'	1,453,771	'	'	'	'	'
Common stock issued in exchange for interest, related party, Amount	'	1,454	'	-1,500	42,528	'	42,482
Common stock issued in exchange for CFO compensation, Shares	'	150,000	'	'	'	'	'
Common stock issued in exchange for CFO compensation, Amount	'	150	'	'	1,350	'	1,500
Common stock issued for consulting services, Shares	'	385,000	'	'	'	'	'
Common stock issued for consulting services, Amount	'	385	'	'	4,165	'	4,550
Options issued in exchange for CFO compensation (Aug 2012)	'	'	'	'	1,500	'	1,500
Options issued in exchange for CFO compensation (Jul 2013)	'	'	'	'	18,000	'	18,000
Beneficial conversion feature	'	'	'	'	72,550	'	72,550
Options issued in exchange for board member services (Aug 2012)	'	'	'	'	5,000	'	5,000
Options issued in exchange for board member services (Jul 2013)	'	'	'	'	60,000	'	60,000
Foregiveness Of Past Salary And Expenses To CEO and Former CFO	'	'	'	'	474,019	'	474,019
Net loss	'	'	'	'	'	-232,681	-232,681
Ending Balance, Amount at Jul. 31, 2013	$1,492	$18,860	'	$54,000	$7,575,567	($7,977,949)	($328,030)
Ending Balance, Shares at Jul. 31, 2013	1,491,743	18,859,005	'	'	'	'	'
[1]	Restated

Consolidated_Condensed_Stateme2

Consolidated Condensed Statement of Cash Flows (USD $)	12 Months Ended
	Jul. 31, 2013		Jul. 31, 2012
Cash flows from operating activities:	'		'
Net loss	($232,681)		($347,772)	[1]
Adjustments to reconcile net loss to net cash used in operating activities:	'		'
Amortization of beneficial conversion feature	20,095		7,498	[1]
Stock based compensation	86,000		115,500	[1]
Consulting expense paid in common stock	4,550		25,360	[1]
Interest expense paid in common stock	37,304		92,050	[1]
Changes in current assets and liabilities:	'		'
Accounts payable and accrued liablities	18,056		29,747	[1]
Accounts payable and accrued liablities, related party	15,954		31,999	[1]
Net cash used in operating activities	-50,722		-45,618	[1]
Cash flows from financing activities:	'		'
Proceeds from notes payable, related party	2,500		9,174	[1]
Proceeds from notes payable	47,050		61,987	[1]
Payment of notes payable	0		-17,000	[1]
Payment of notes payable, related party	0		-4,000	[1]
Net cash provided by financing activities	49,550		50,161	[1]
Net change in cash	-1,172		4,543	[1]
Cash, beginning of period	4,709	[1]	166	[1]
Cash, end of period	3,537		4,709	[1]
Cash paid during the period for:	'		'
Income taxes	0		0	[1]
Interest	0		0	[1]
Non-cash investing/financing activities	'		'
Stock issued for conversion of accrued interest	5,178		5,850	[1]
Beneficial Conversion Feature - Debt	72,550		6,000	[1]
Debt relief by directors	474,019		0	[1]
Transfer to debt	45,500		0	[1]
Common shares issued out of stock payable	$1,500		$0	[1]
[1]	Restated

1_Organization_and_Basis_of_Pr

1. Organization and Basis of Presentation	12 Months Ended
	Jul. 31, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Organization and Basis of Presentation	'
	Organization and Basis of Presentation
	Worldwide Strategies Incorporated (the "Company") was originally incorporated in the state of Nevada on April 6, 1998.  On March 1, 2005, Worldwide Business Solutions Incorporated ("WBSI") was incorporated in the State of Colorado.  On July 8, 2005, the Company acquired all the shares of WBSI for 76.8% of the Company's outstanding stock.  The acquisition of WBSI has been accounted for as a recapitalization of WBSI.  Therefore the historical information prior to the date of recapitalization is the financial information of WBSI.
	Effective July 31, 2007 the Company filed a Certificate of Change Pursuant to NRS 78.209, which decreased the number of its authorized shares of common stock from 100,000,000 to 33,333,333 and reduced the number of common shares issued and outstanding from 17,768,607 to 5,923,106.
	All shares and per share amounts in these Consolidated Financial Statements and related notes have been retroactively adjusted to reflect the reverse stock split for all periods presented.
	On July 31, 2007, the Company acquired 100% of the issued and outstanding shares of Centric Rx, Inc., ("Centric") in exchange for 2,250,000 shares of the Company's common stock.  As a result of the acquisition, Centric became a wholly owned subsidiary of the Company and the results of its operation have been included in the Company's consolidated financial statements since the date of acquisition.
	Development Stage
	In June 2014, the FASB issued ASU No. 2014-10: Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements to improve financial reporting by reducing cost and complexity associated with the incremental reporting requirements of development stage entities.  The changes eliminate the need for inception to date reporting and other disclosure requirements.  The amendments are effective for annual reporting periods beginning after December 15, 2014.  Early adoption is permitted.  The Company has elected early adoption of these amendments.
	Going Concern
	The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States, which contemplate continuation of the Company as a going concern.  However, the Company experienced net losses of $232,681, $347,772, and $7,977,949 for the years ended July 31, 2013 and 2012 and for the period from March 1, 2005 (inception) through July 31, 2013, respectively.  In addition, the Company has incurred liabilities in excess of assets over the past year and, as of July 31, 2013, has an accumulated deficit of $7,977,949. These matters, among others, raise substantial doubt about its ability to continue as a going concern.
	In view of the matters described above, recoverability of a major portion of the recorded asset amounts shown in the accompanying balance sheet is dependent upon the Company's ability to generate sufficient sales volume to cover its operating expenses and to raise sufficient capital to meet its payment obligations.  Historically, management has been able to raise additional capital. During the year ended July 31, 2013, the Company issued convertible promissory notes in exchange for $49,550.
	The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence.
	Principles of Consolidation
	The accompanying Consolidated Financial Statements include the Company's accounts and those of its wholly owned subsidiaries.  All significant intercompany transactions and balances have been eliminated in consolidation.
	Use of Estimates
	The preparation of financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.
	Cash and Cash Equivalents
	The Company considers all highly liquid debt instruments with original maturities of three months or less when acquired to be cash equivalents.  The Company had no cash equivalents at July 31, 2013 or 2012.
	Financial Instruments
	The carrying amounts of cash and current liabilities approximate fair value due to the short-term maturity of the instruments.
	Property and Equipment
	Property and equipment are stated at cost.  Depreciation is calculated using the straight-line method over the estimated useful lives of the related assets, currently ranging from three to five years.  Expenditures for additions and improvements are capitalized, while repairs and maintenance costs are expensed as incurred.  The cost and related accumulated depreciation of property and equipment sold or otherwise disposed of are removed from the accounts and any gain or loss is recorded in the year of disposal.
				July 31,
				2013			2012
		Office equipment		$	10,600		$	10,600
		Software			12,023			12,023
					22,623			22,623
		Accumulated depreciation			22,623			22,623
		Property and equipment - net		$	0		$	0
	Depreciation expense for the years ended July 31, 2013 and 2012 and for the period from March 1, 2005 (inception) through July 31, 2013 totaled $-0-, $-0-, and $140,278, respectively.
	Impairment of Long-Lived Assets
	The Company has adopted ASC 360, "Accounting for the Impairment or Disposal of Long-Lived Assets," which requires that long-lived assets to be held be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  ASC 360 establishes a single auditing model for long-lived assets to be disposed of by sale.
	Loss per Common Share
	The Company reports net loss per share using a dual presentation of basic and diluted loss per share. Basic earnings (loss) per share are computed by dividing the net income (loss) by the weighted-average number of shares of common stock and common stock equivalents (primarily outstanding options and convertible preferred stock). Common stock equivalents represent the dilutive effect of the assumed exercise of the outstanding stock options and convertible preferred stock, using the treasury stock method. The calculation of fully diluted earnings (loss) per share assumes the dilutive effect of the exercise of outstanding options and convertible preferred stock at either the beginning of the respective period presented or the date of issuance, whichever is later. At July 31, 2013 and 2012, the Company had outstanding options equivalent to 4,333,328 and 3,508,328 common shares respectively and convertible preferred stock equivalent to 9,323,400 common shares.
	Stock-based Compensation
	The Company accounts for all stock-based payments to employees and non-employees under ASC 718 "Stock Compensation," using the fair value based method. Under the fair value method, stock-based payments are measured at the fair value of the consideration received, or the fair value of the equity instruments issued, or liabilities incurred, whichever is more reliably measurable. The cost of stock-based payments to non-employees that are fully vested and non-forfeitable at the grant date is measured and recognized at that date.
	Beneficial Conversion Features
	From time to time, the Company may issue convertible notes that contain an imbedded beneficial conversion feature. A beneficial conversion feature exists on the date a convertible note is issued when the fair value of the underlying common stock to which the note is convertible into is in excess of the remaining unallocated proceeds of the note after first considering the allocation of a portion of the note proceeds to the fair value of warrants, if related warrants have been granted. The intrinsic value of the beneficial conversion feature is recorded as a debt discount with a corresponding amount to additional paid in capital. The debt discount is amortized to interest expense over the life of the note using the effective interest method.
	Fair Value of Financial Instruments
	On August 1, 2012, the Company adopted ASC 820, Fair Value Measurements and Disclosures.  ASC 820 defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The three levels are defined as follows:
	Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
	Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
	Level 3 inputs to valuation methodology are unobservable and significant to the fair measurement.
	The following table represents our assets and liabilities by level measured at fair value on a recurring basis at July 31, 2013:
	Description		Level 1			Level 2		Level 3		Total
										Realized
										Loss
		$	-		$	-	$	-	$	-
	Totals	$	-		$	-	$	-	$	-
	Fiscal Year-end
	The Company's year-end is July 31.
	New Accounting Pronouncements
	In June 2014, the FASB issued ASU 2014-10, Development Stage Entities. The amendments in this update remove the definition of a development stage entity from the Master Glossary of the ASC thereby removing the financial reporting distinction between development stage entities and other reporting entities from U.S. GAAP. In addition, the amendments eliminate the requirements for development stage entities to (1) present inception-to-date information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. The amendments in this update are applied retrospectively. The adoption of ASU 2014-10 removed the development stage entity financial reporting requirements from the Company.
	In July 2013, the FASB issued ASU No. 2013-11: Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carry forward, a Similar Tax Loss, or a Tax Credit Carry forward Exists. The new guidance
	requires that unrecognized tax benefits be presented on a net basis with the deferred tax assets for such carry forwards. This new guidance is effective for fiscal years and interim periods within those years beginning after December 15, 2013. We do not expect the adoption of the new provisions to have a material impact on our financial condition or results of operations.
	In February 2013, the FASB issued ASU No. 2013-02, Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, to improve the transparency of reporting these reclassifications. Other comprehensive income includes gains and losses that are initially excluded from net income for an accounting period. Those gains and losses are later reclassified out of accumulated other comprehensive income into net income. The amendments in the ASU do not change the current requirements for reporting net income or other comprehensive income in financial statements. All of the information that this ASU requires already is required to be disclosed elsewhere in the financial statements under U.S. GAAP. The new amendments will require an organization to:
	Present (either on the face of the statement where net income is presented or in the notes) the effects on the line items of net income of significant amounts reclassified out of accumulated other comprehensive income - but only if the item reclassified is required under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period; and
	Cross-reference to other disclosures currently required under U.S. GAAP for other reclassification items (that are not required under U.S. GAAP) to be reclassified directly to net income in their entirety in the same reporting period. This would be the case when a portion of the amount reclassified out of accumulated other comprehensive income is initially transferred to a balance sheet account (e.g., inventory for pension-related amounts) instead of directly to income or expense.
	The amendments apply to all public and private companies that report items of other comprehensive income. Public companies are required to comply with these amendments for all reporting periods (interim and annual). The amendments were effective for reporting periods beginning after December 15, 2012, for public companies. Early adoption was permitted. The adoption of ASU No. 2013-02 did not have a material impact on our financial position or results of operations.
	In January 2013, the FASB issued ASU No. 2013-01, Balance Sheet (Topic 210): Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities, which clarifies which instruments and transactions are subject to the offsetting disclosure requirements originally established by ASU 2011-11. The new ASU addresses preparer concerns that the scope of the disclosure requirements under ASU 2011-11 was overly broad and imposed unintended costs that were not commensurate with estimated benefits to financial statement users. In choosing to narrow the scope of the offsetting disclosures, the Board determined that it could make them more operable and cost effective for preparers while still giving financial statement users sufficient information to analyze the most significant presentation differences between financial statements prepared in accordance with U.S. GAAP and those prepared under IFRSs. Like ASU 2011-11, the amendments in this update were effective for fiscal periods beginning on, or after January 1, 2013. The adoption of ASU 2013-01 did not have a material impact on our financial position or results of operations.
	In October 2012, the FASB issued ASU 2012-04, Technical Corrections and Improvements. The amendments in this update cover a wide range of Topics in the Accounting Standards Codification. These amendments include technical corrections and improvements to the Accounting Standards Codification and conforming amendments related to fair value measurements. The amendments in this update were effective for fiscal periods beginning after December 15, 2012. The adoption of ASU 2012-04 did not have a material impact on our financial position or results of operations.
	In August 2012, the FASB issued ASU 2012-03, Technical Amendments and Corrections to SEC Sections: Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin (SAB) No. 114, Technical Amendments Pursuant to SEC Release No. 33-9250, and Corrections Related to FASB Accounting Standards Update 2010-22 (SEC Update). This update amends various SEC paragraphs pursuant to the issuance of SAB No. 114. The adoption of ASU 2012-03 did not have a material impact on our financial position or results of operations.
	In July 2012, the FASB issued ASU 2012-02, Intangibles – Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment. This update amends ASU 2011-08, Intangibles – Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment and permits an entity first to assess qualitative factors to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired as a basis for determining whether it is necessary to perform the quantitative impairment test in accordance with Subtopic 350-30, Intangibles - Goodwill and Other - General Intangibles Other than Goodwill. The amendments were effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. Early adoption was permitted, including for annual and interim impairment tests performed as of a date before July 27, 2012, if a public entity's financial statements for the most recent annual or interim period have not yet been issued or, for nonpublic entities, had not yet been made available for issuance. The adoption of ASU 2012-02 did not have a material impact on our financial position or results of operations.
	Beneficial Conversion Feature
From time to time, the Company may issue convertible notes that contain an imbedded beneficial conversion feature. A beneficial conversion feature exists on the date a convertible note is issued when the fair value of the underlying common stock to which the note is convertible into is in excess of the remaining unallocated proceeds of the note after first considering the allocation of a portion of the note proceeds to the fair value of warrants, if related warrants have been granted. The intrinsic value of the beneficial conversion feature is recorded as a debt discount with a corresponding amount to additional paid in capital. The debt discount is amortized to interest expense over the life of the note using the effective interest method.
Financial Instruments
On August 1, 2012, the Company adopted Accounting Standards Codification Topic 820, Fair Value Measurements and Disclosures ("Topic 820").  Topic 820 defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The three levels are defined as follows:
Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
Level 3 inputs to valuation methodology are unobservable and significant to the fair measurement.
The following table represents our assets and liabilities by level measured at fair value on a recurring basis at July 31, 2013:
Description		Level 1			Level 2		Level 3		Total
									Realized
									Loss
	$	-		$	-	$	-	$	-
Totals	$	-		$	-	$	-	$	-

2_Accounts_payable_related_par

2. Accounts payable related parties	12 Months Ended
	Jul. 31, 2013
Accounts Payable [Abstract]	'
Accounts payable related parties	'
	At July 31, 2013 and 2012, the Company was indebted to related parties for expenses incurred on behalf of the Company totaling $3,900.

3_Accrued_compensation

3. Accrued compensation	12 Months Ended
	Jul. 31, 2013
Accrued Liabilities [Abstract]	'
Accrued compensation	'
	At July 31, 2013 and 2012, accrued compensation totaled $-0- and $410,625 respectively. The CEO and former CFO forgave this liability in exchange for convertible promissory notes totaling $45,500 in value, including amounts related to Accrued Liabilities forgiven.  The difference was recorded to Paid In Capital on the balance sheet.

4_Related_party_transactions

4. Related party transactions	12 Months Ended
	Jul. 31, 2013
Related Party Transactions [Abstract]	'
Related party transactions	'
	Accrued liabilities
	At July 31, 2013 and 2012, accrued liabilities totaled $1,544 and $100,523 respectively.  During the 2013 fiscal year the CEO incurred $8,321 expenses related to Company efforts.  The CEO forgave accrued expenses of $108,844 in exchange for convertible promissory notes totaling $45,500 in value, including amounts related to Accrued Liabilities forgiven.  The difference was recorded to Paid In Capital on the balance sheet.  An additional amount of $1,065 represents accrued interest expense on notes payable to related parties for 2013.
	Notes payable
	During May 2010, the Company issued a convertible promissory note to a related party in exchange for $50,000. The note bears interest at 9% and the principal and accrued interest is convertible into common shares at $.04 per share upon the election of the holder. The note also provide for renewal in 120-day cycles, assuming issuing of common stock as a renewal premium.  Interest expense for this note payable was $3,188 and $4,500 and the renewal premium recorded as interest expense for this note was $20,050 and $101,592 for the years ended July 31, 2013 and 2012, respectively.  This note was exchanged in April 2013 for new promissory notes bearing interest at 10% and convertible into common shares at $.01 per share with a 120-day renewal cycle and identical renewal premium.  The new promissory notes allow the Company to call the note and pay it off, a feature not available in the prior promissory note.
	During December 2010, the Company issued a convertible promissory note to a related party in exchange for $15,000. The note bears interest at 9% and the principal and accrued interest is convertible into common shares at $.04 per share upon the election of the holder. The note also provide for renewal in 120-day cycles, assuming issuing of common stock as a renewal premium.  Interest expense for this note payable was $956 and $1,350 and the renewal premium recorded as interest expense for this note was $13,400 and $17,799 for the years ended July 31, 2013 and 2012, respectively. This note was exchanged in April 2013 for new promissory notes bearing interest at 10% and convertible into common shares at $.01 per share with a 120-day renewal cycle and identical renewal premium.  The new promissory notes allow the Company to call the note and pay it off, a feature not available in the prior promissory note.
	During May 2011, the Company issued two convertible promissory notes to related parties in exchange for a total of $4,000.  The notes bear interest at 10% and the principal and accrued interest is convertible into common shares at $.07 per share upon the election of the holder.  In November 2011 these notes were exchanged for new convertible promissory notes totaling $4,173 in principal and accrued interest.
	During November 2011, the Company issued two convertible promissory notes to related parties in exchange for $4,173 of principal and accrued interest on due promissory notes. The notes bear interest at 10% and the principal and accrued interest is convertible into common shares at $.07 per share upon the election of the holders, as did the notes being replaced. Interest expense for these notes was $418 and $313 for the years ended July 31, 2013 and 2012, respectively.  Based on the initial valuation the Company has recorded a debt discount of $2,340, all of which was amortized in the fiscal year ending July 31, 2012.  The original maturity date on these notes was April 30, 2012.  The holders have extended both notes to July 31, 2015.
	During April 2012, the Company issued a convertible promissory note to a related party in exchange for a total of $5,000.  The note bears interest at 10% and the principal and accrued interest is convertible into common shares at $.04 per share upon the election of the holder.  Interest expense for this note was $500 and $167 for the years ended July 31, 2013 and 2012, respectively.  Based on the initial valuation the Company has recorded a debt discount of $1,250, $831 of which was amortized in the fiscal year ended July 31, 2012 and the remaining $419 amortized in the fiscal year ending July 31, 2013.  The original maturity date on this note was September 30, 2012.  The holder has extended the note to July 31, 2015.
	During December 2012, the Company issued two promissory notes to two related parties totaling $2,000. The notes bear interest at 10% and the principal and accrued interest are convertible into common shares at $.01 per share.  Interest expense for these notes was accrued in the amount of $123 for the year ended July 31, 2013.  Based on the initial valuation the Company has recorded a debt discount of $2,000, all of which was amortized in the fiscal year ending July 31, 2013.  The original maturity date on these notes was June 30, 2013.  The holders have extended the notes to July 31, 2015.
	During February 2013, the Company issued one promissory note to a related party for $500.  The note bears interest at 10% and the principal and accrued interest are convertible into common shares at $.01 per share.  This note was related to company expenses paid.  Interest expense for this note was accrued in the amount of $25 for the year ended July 31, 2013. Based on the initial valuation the Company has recorded a debt discount of $500, $427 of which was amortized in the fiscal year ended July 31, 2013.  The original maturity date on this note was August 31, 2013.  The holder has extended the note to July 31, 2015.
	During April 2013, the Company issued five convertible promissory notes to related parties in exchange for two promissory notes totaling $65,000. The notes bear interest at 10% and the principal and accrued interest is convertible into common shares at $.01 per share upon the election of the holder.  These notes have a 120-day term and are renewed with payment of accrued interest in common stock as well as a renewal fee of 455,000 shares.  The common shares for this renewal fee were issued May 14, 2013 and valued at $13,577.  Interest expense for these notes was $1,896 for the year ended July 31, 2013.  These notes were replaced through renewal July 2013.
	During July 2013, the Company issued one promissory note to a related party for $28,500.  The note bears interest at 10% and the principal and accrued interest are convertible into common shares at $.01 per share.  This note was in exchange for accrued and owed salary of $241,875 and accrued and owed expense of $108,844.  There was no interest expense for this note for the year ended July 31, 2013. Based on the initial valuation the Company has recorded a debt discount of $28,500, none of which was amortized in the fiscal year ended July 31, 2013.  The original maturity date on this note was January 31, 2014.  The holder has extended the note to July 31, 2015.
	During July 2013, the Company issued one promissory note to a related party for $17,000.  The note bears interest at 10% and the principal and accrued interest are convertible into common shares at $.01 per share.  This note was in exchange for accrued and owed salary of $168,750 to the Company's former CFO.  There was no interest expense for this note for the year ended July 31, 2013.  Based on the initial valuation the Company has recorded a debt discount of $17,000, none of which was amortized in the fiscal year ended July 31, 2013.  The original maturity date on this note was January 31, 2014.  As of this time the holder has not responded to a request to extend the note maturity date and the note is in default and payable on demand by the holder.
	During July 2013, the Company issued five convertible promissory notes to related parties in exchange for five promissory notes totaling $65,000. The notes bear interest at 10% and the principal and accrued interest is convertible into common shares at $.01 per share upon the election of the holder.  These notes have a 120-day term and are renewed with payment of accrued interest in common stock as well as a renewal fee of 455,000 shares.  The common shares for this renewal fee were issued August 5, 2013 and valued at $26,845.  Interest expense for these notes was $1,896 for the year ended July 31, 2013.  These notes matured December 11, 2013 and the holders chose not to renew per the note terms.  The notes are in default and payable on demand of the holders.
	As of July 31, 2013, the Company had outstanding convertible promissory notes to nine related parties totaling $122,173. The notes bear interest at 10% and the principal and accrued interest is convertible into common shares, with $4,173 convertible at $.07 per share, $5,000 convertible at $.04 per share and $113,000 convertible at $.01 per share upon the election of the holder. Interest expense for these notes was $7,105 and $6,330 for the years ended July 31, 2013 and 2012 respectively.  The Company reported Debt Discount of $51,590 on these notes of which $3,171 and $2,846 was amortized in the fiscal years ended July 31, 2012 and July 31, 2013 respectively.  $45,573 Debt Discount remains unamortized as of July 31, 2013.
	Preferred stock
	In December 2008, outstanding notes, including accrued interest, which was capitalized, totaling $322,981 were repaid with the issuance of 645,962 shares of preferred stock. An additional note in the amount of $10,000 was issued to the CEO for cash in April 2009. The note, including $210 in accrued interest, was repaid by issuing 20,420 shares of preferred stock in July 2009.
	In May 2010, five directors and two officers were each issued 7,500 preferred shares totaling 52,500 shares in exchange for uncompensated services. This amount ($26,250) is reflected in the accompanying financial statements as stock based compensation.
	Common stock
	In August 2011, the Company issued 300,000 shares of the Company's common stock in exchange for uncompensated services provided to the Company by four directors.  The shares were valued at $.12 per share based on the fair value of the shares on the day they were granted. This amount ($36,000) is reflected in the accompanying financial statements as stock based compensation.
	In August 2011, the Company approved issuance of 300,000 shares of the Company's common stock in February 2012 in exchange for uncompensated services provided to the Company by four directors during Fiscal 2013.  Issuance of these shares was not done and Stock Payable of $54,000 and $55,500 as of July 31, 2013 and 2012 respectively has been recorded based on the value of the unissued shares at those dates.
	In September 2011, the Company issued 387,500 shares of the Company's common stock in exchange for accrued interest and an extension of due date from September 18, 2011 to January 16, 2012 on a note payable. The shares related to the accrued interest were issued at $.04 per share and the shares related to the extension were issued at $.15 per share (fair market value) on the day they were granted, per the terms of the agreement.  This amount ($54,000) is reflected in the accompanying financial statements as interest.
	In November 2011, the Company issued 116,250 shares of the Company's common stock in exchange for accrued interest and an extension of due date from November 28, 2011 to March 27, 2012 on a note payable. The shares related to the accrued interest were issued at $.04 per share and the shares related to the extension were issued at $.05 per share (fair market value) on the day they were granted, per the terms of the agreement.  This amount ($5,700) will be reflected in the accompanying financial statements as interest.
	In December 2011, the Company issued 150,000 shares of the Company's common stock in exchange for uncompensated services provided to the Company by the VP Finance & CFO.  The shares were valued at $.04 per share based on the fair value of the shares on the day they were granted. This amount ($6,000) is reflected in the accompanying financial statements as stock based compensation.
	In January 2012, the Company issued 387,500 shares of the Company's common stock in exchange for accrued interest and an extension of due date from January 16, 2012 to May 15, 2012 on a note payable. The shares related to the accrued interest were issued at $.04 per share and the shares related to the extension were issued at $.05 per share (fair market value) on the day they were granted, per the terms of the agreement.  This amount ($19,000) is reflected in the accompanying financial statements as interest.
	In March 2012, the Company issued 150,000 shares of the Company's common stock in exchange for uncompensated services provided to the Company by the VP Finance & CFO.  The shares were valued at $.05 per share based on the fair value of the shares on the day they were granted. This amount ($7,500) is reflected in the accompanying financial statements as stock based compensation.
	In March 2012, the Company issued 116,250 shares of the Company's common stock in exchange for accrued interest and an extension of due date from March 27, 2012 to July 25, 2012 on a note payable. The shares related to the accrued interest were issued at $.04 per share and the shares related to the extension were issued at $.05 per share (fair market value) on the day they were granted, per the terms of the agreement.  This amount ($5,700) is reflected in the accompanying financial statements as interest.
	In May 2012, the Company issued 387,500 shares of the Company's common stock in exchange for accrued interest and an extension of due date from July 25, 2012 to September 12, 2012 on a note payable. The shares related to the accrued interest were issued at $.04 per share and the shares related to the extension were issued at $.03 per share (fair market value) on the day they were granted, per the terms of the agreement.  This amount ($12,000) is reflected in the accompanying financial statements as interest.
	In August 2012, the Company issued 150,000 shares of the Company's common stock in exchange for uncompensated services provided to the company by the VP Finance & CFO.  The shares were valued at $.01 per share based on the fair value of the shares on the day they were granted. This amount ($1,500) is reflected in the accompanying financial statements as stock based compensation.
	In August 2012, the Company issued 116,250 shares of the Company's common stock in exchange for accrued interest and an extension of due date from July 25, 2012 to November 22, 2012 on a note payable. The shares related to the accrued interest were issued at $.04 per share and the shares related to the extension were issued at $.01 per share (fair market value) on the day they were granted, per the terms of the agreement.  This amount ($1,500) will be reflected in the accompanying financial statements as interest.
	In September 2012, the Company issued 387,500 shares of the Company's common stock in exchange for accrued interest and an extension of due date from September 12, 2012 to January 10, 2013 on a note payable. The shares related to the accrued interest were issued at $.04 per share and the shares related to the extension were issued at $.01 per share (fair market value) on the day they were granted, per the terms of the agreement.  This amount ($5,000) is reflected in the accompanying financial statements as interest.
	In December 2012, the Company issued 116,250 shares of the Company's common stock in exchange for accrued interest and an extension of due date from November 22, 2012 to January 10, 2013 on a note payable. The shares related to the accrued interest were issued at $.04 per share and the shares related to the extension were issued at $.03 per share (fair market value) on the day they were granted, per the terms of the agreement.  This amount ($3,488) will be reflected in the accompanying financial statements as interest.
	In February 2013, the Company issued 387,500 shares of the Company's common stock in exchange for accrued interest and an extension of due date from January 10, 2013 to May 10, 2013 on a note payable. The shares related to the accrued interest were issued at $.04 per share and the shares related to the extension were issued at $.03 per share (fair market value) on the day they were granted, per the terms of the agreement.  This amount ($11,625) will be reflected in the accompanying financial statements as interest.
	In March 2013, the Company issued 116,250 shares of the Company's common stock in exchange for accrued interest and an extension of due date from March 22, 2013 to July 20, 2013 on a note payable. The shares related to the accrued interest were issued at $.04 per share and the shares related to the extension were issued at $.05 per share (fair market value) on the day they were granted, per the terms of the agreement.  This amount ($3,600) will be reflected in the accompanying financial statements as interest.
	In May 2013, the Company issued 330,021 shares of the Company's common stock in exchange for accrued interest and an exchange for replacement on two notes payable. The shares related to the accrued interest were issued at $.04 per share and the shares related to the extension were issued at $.05 per share (fair market value) on the day they were granted, per the terms of the agreement.  This amount ($16,182) is reflected in the accompanying financial statements as interest.
	In June 2014, the FASB issued ASU No. 2014-10: Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements to improve financial reporting by reducing cost and complexity associated with the incremental reporting requirements of development stage entities.  The changes eliminate the need for inception to date reporting and other disclosure requirement.  The amendments are effective for annual reporting periods beginning after December 15, 2014.  Early adoption is permitted.  The Company has elected early adoption of these amendments.

5_Notes_payable

5. Notes payable	12 Months Ended
	Jul. 31, 2013
Notes Payable [Abstract]	'
Notes payable	'
	During November 2009, the Company issued a convertible promissory note to an unrelated third party in exchange for $25,000. The note bears interest at 8% and the principal and accrued interest is convertible, at the option of the note-holder, into non-restricted common stock in an amount equal to the total sum due, based on a mutually agreed discount (not to exceed 50%) to the then market price. Interest expense for this note payable was $3,000 and $2,000 for the years ended July 31, 2013 and 2012, respectively.  The original maturity date on this note was May 31, 2010.  The holder has extended the note to March 31, 2015.
	During February 2010, the Company issued a convertible promissory note to an unrelated third party in exchange for $25,000. The note bears interest at 8% and the principal and accrued interest is convertible, at the option of the note-holder, into non-restricted common stock in an amount equal to the total sum due, based on a mutually agreed discount (not to exceed 50%) to the then market price. Interest expense for this note payable was $3,000 and $2,000 for the years ended July 31, 2013 and 2012, respectively. The original maturity date on this note was July 31, 2010.  The holder has extended the note to March 31, 2015.
	During October 2011, the Company issued a convertible promissory note to an unrelated party in exchange for $15,000. The note bears interest at 10% and the principal and accrued interest is convertible into common shares at $.07 per share upon the election of the holder. Interest expense for this note was $1,500 and $1,150 for the years ended July 31, 2013 and 2012, respectively.  The original maturity date on this note was April 25, 2012.  The holder has extended the note to July 31, 2015.
	During November 2011, the Company issued a convertible promissory note to an unrelated party in exchange for $2,087 of principal and accrued interest on a due promissory note. The terms of the new note match those of the note being replaced.  The note bear interest at 10% and the principal and accrued interest is convertible into common shares at $.07 per share upon the election of the holder, as did the notes being replaced. Interest expense for the note was $209 and $157 for the years ended July 31, 2013 and 2012, respectively. The original maturity date on this note was April 30, 2012.  The holder has extended the note to July 31, 2015.
	During March 2012, the Company issued a convertible promissory note to an unrelated party to replace a note due, including accrued interest, of $15,750.  The terms of the new note match those of the note being replaced.  The note bears interest at 10% and the principal and accrued interest is convertible into common shares at $.07 per share upon the election of the holder.  Interest expense for this note was $1,575 and $656 for the years ended July 31, 2013 and 2012, respectively. The original maturity date on this note was August 31, 2012.  The holder has extended the note to July 31, 2015.
	During March 2012, the Company issued a convertible promissory note to an unrelated party in exchange for $2,150.  The note bears interest at 10% and the principal and accrued interest is convertible into common shares at $.07 per share upon the election of the holder.  Interest expense for this note was $215 and $84 for the years ended July 31, 2013 and 2012, respectively. The original maturity date on this note was September 12, 2012.  The holder has extended the note to July 31, 2015.
	During April 2012, the Company issued convertible promissory notes to four unrelated parties in exchange for a total of $12,000.  The notes bear interest at 10% and the principal and accrued interest is convertible into common shares at $.04 per share upon the election of the holder of each note.  Interest expense for these notes was $1,200 and $400 for the years ended July 31, 2013 and 2012, respectively. Based on the initial valuation the Company has recorded a debt discount of $4,750, $3,158 of which was amortized in the fiscal year ended July 31, 2012 and $1,592 amortized in the fiscal year ended July 31, 2013.  The original maturity date on these notes was September 30, 2012.  The holders have extended the notes to July 31, 2015.
	During July 2012, the Company issued a convertible promissory note to an unrelated party in exchange for $15,000.  The note bears interest at 10% and the principal and accrued interest is convertible into common shares at $.01 per share upon the election of the holder.  Interest expense for this note was $1,529 and $0 for the years ended July 31, 2013 and 2012, respectively. The original maturity date on this note was January 31, 2013.  The holder has extended the note December 31, 2014.
	During October 2012, the Company issued convertible promissory notes to five unrelated parties in exchange for a total of $7,500.  The notes bear interest at 10% and the principal and accrued interest is convertible into common shares at $.01 per share upon the election of the holder of each note.  Interest expense for these notes was $625 for the year ended July 31, 2013.  The original maturity date on these notes was March 31, 2013.  The holders have extended the notes to July 31, 2015.
	During January 2013, the Company issued three promissory notes to one unrelated party for a total of $12,500.  The notes bear interest at 10% and the principal and accrued interest is convertible into common shares at $.01 per share upon the election of the holder of each note. Interest expense for these notes was $649 for the year ended July 31, 2013.  Based on the initial valuation the Company has recorded a debt discount of $12,500, all of which was amortized in the fiscal year ended July 31, 2013.  The original maturity date on these notes was July 31, 2013.  The holder has extended the notes to December 31, 2014.
	During June 2013, the Company issued convertible promissory notes to three unrelated parties in exchange for a total of $8,500. The notes bear interest at 10% and the principal and accrued interest is convertible into common shares at $.01 per share upon the election of the holder of each note.  Interest expense for these notes was $122 for the year ended July 31, 2013. Based on the initial valuation the Company has recorded a debt discount of $8,500, $2,558 of which was amortized in the fiscal year ended July 31, 2013.  The original maturity date on these notes was November 30, 2013.  The holders have extended the notes to December 31, 2014.
	During June 2013, the Company issued a convertible promissory note to an unrelated party valued at $3,550 as compensation for consulting services.  The note bears interest at 10% and the principal and accrued interest is convertible into common shares at $.01 per share upon the election of the holder.  Interest expense for this note was $46 for the year ended July 31, 2013. Based on the initial valuation the Company has recorded a debt discount of $3,550, $848 of which was amortized in the fiscal year ended July 31, 2013.  The original maturity date on this notes was December 31, 2013.  The holder has extended the note to December 31, 2014.

6_Shareholders_Deficit

6. Shareholders' Deficit	12 Months Ended
	Jul. 31, 2013
Stockholders' Equity Note [Abstract]	'
Shareholders' Deficit	'
	Preferred stock
	The Company is authorized to issue 25,000,000 shares of $.001 par value preferred stock. The Company's Board of Directors may divide and issue the preferred shares in series. Each Series, when issued, shall be designated to distinguish them from the shares of all other series. The relative rights and preferences of these series include preference of dividends, redemption terms and conditions, amount payable upon shares of voluntary or involuntary liquidation, terms and condition of conversion as well as voting powers.
	In December 2008, the Company designated 5,000,000 shares of preferred stock as Series A Convertible Preferred Stock ("Series A"). Each share of Series A is convertible into 6.25 shares of common stock at the election of the holder. Each Series A share is entitled to 6.25 votes in any vote of the common stock holders. Series A shares are redeemable by the Company at $.50 per share with 15 days written notice. Series A shares are entitled to a 5% dividend preference and a participation interest in the remaining 95% dividend.
	Effective January 31, 2009, the Company issued 658,589 Series A shares at $.50 in full settlement of notes payable and accrued interest in the amount of $329,294.
	Also effective January 31, 2009, an additional 16,000 Series A shares were issued for $8,000 in cash.
	In July 2009, the Company issued 37,672 Series A shares at $.50 in full settlement of notes payable and accrued interest in the amount of $18,836.
	In May 2010, the Company issued 3,200 preferred shares at $.50 for cash in the amount of $1,600.
	In May 2010, a consultant was issued 15,000 preferred shares in exchange for consulting services. This amount ($7,500) is reflected in the accompanying financial statements as professional and consulting fees.
	In June 2010, an outstanding note, including accrued interest, which was capitalized, totaling $21,200 was repaid with the issuance of 42,400 shares of preferred stock.
	Common stock
	In December 2011, the Company issued 189,000 shares of the Company's common stock, valued at $9,450, in exchange for services to be rendered. The shares were valued based on the fair value on the date of grant and are reflected in the accompanying financial statements as professional and consulting fees.
	In December 2011, the Company issued 15,000 shares of the Company's common stock, valued at $750, in exchange for services to be rendered. The shares were valued based on the fair value on the date of grant and are reflected in the accompanying financial statements as professional and consulting fees.
	In January 2012, the Company issued 100,000 shares of the Company's stock, valued at $5,000, in exchange for services to be rendered. The shares were valued based on the fair value on the date of grant and are reflected in the accompanying financial statements as professional and consulting fees.
	In March 2012, the Company issued 15,000 shares of the Company's common stock in exchange for services to be rendered.  The shares were valued at $.05 per share based on the fair value of the shares when they were granted.  The amount ($750) is reflected in the accompanying financial statements as consulting fees.
	In March 2012, the Company issued 15,000 shares of the Company's common stock in exchange for services to be rendered.  The shares were valued at $.03 per share based on the fair value of the shares when they were granted.  The amount ($450) is reflected in the accompanying financial statements as consulting fees.
	In July 2012, the Company issued 300,000 shares of the Company's common stock in exchange for services rendered.  The shares were valued at $.04 per share based on the fair value of the shares when they were granted.  The amount ($12,000) is reflected in the accompanying financial statements as consulting fees.
	In September 2012, the Company issued 350,000 shares of the Company's common stock in exchange for services valued at $3,500. The shares were valued based on the fair value on the date of grant, $.03 per share, and are reflected in the accompanying financial statements as professional and consulting fees.
	In December 2012, the Company issued 35,000 shares of the Company's common stock to two individuals in exchange for services valued at $3,500. The shares were valued based on the fair value on the date of grant, $.01 per share, and are reflected in the accompanying financial statements as professional and consulting fees.
	Options granted to employees, accounted for under the fair value method
	Effective February 1, 2006, the Company adopted ASC 718 Stock Based Payment which requires a public entity to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions).
	In November 2011, the Company granted the VP Finance & CFO options to purchase an aggregate of 150,000 shares of the Company's common stock at an exercise price of $.15 per share, in exchange for unpaid services expenses.  All 150,000 options were fully vested on the grant date.  The quoted market price of the stock was $.04 per share on the grant date.  The Company valued the options at $.04 per share, or $6,000.  This amount is reflected in the accompanying financial statements as stock based compensation.  The fair value of the options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:
	Risk-free interest rate	0.90%
	Dividend yield	0.00%
	Volatility factor	302.56%
	Weighted average expected life	5 years
	In March 2012, the Company granted the VP Finance & CFO options to purchase an aggregate of 150,000 shares of the Company's common stock at an exercise price of $.15 per share, in exchange for unpaid services expenses.  All 150,000 options were fully vested on the grant date.  The quoted market price of the stock was $.04 per share on the grant date.  The Company valued the options at $.04 per share, or $6,000.  This amount is reflected in the accompanying financial statements as stock based compensation.  The fair value of the options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:
	Risk-free interest rate	0.90%
	Dividend yield	0.00%
	Volatility factor	281.50%
	Weighted average expected life	5 years
	In August 2012, the Company granted two officers and four directors options to purchase an aggregate of 500,000 shares of the Company's common stock at an exercise price of $.01 per share, in exchange for unpaid services expenses.  All 500,000 options were fully vested on the grant date.  The quoted market price of the stock was $.01 per share on the grant date.  The Company valued the options at $.01 per share, or $5,000.  This amount is reflected in the accompanying financial statements as stock based compensation.  The fair value of the options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:
	Risk-free interest rate	0.63%
	Dividend yield	0.00%
	Volatility factor	273.47%
	Weighted average expected life	7 years
	In August 2012, the Company granted the VP Finance & CFO options to purchase an aggregate of 150,000 shares of the Company's common stock at an exercise price of $.01 per share, in exchange for unpaid services expenses.  All 150,000 options were fully vested on the grant date.  The quoted market price of the stock was $.01 per share on the grant date.  The Company valued the options at $.01 per share, or $1,500.  This amount is reflected in the accompanying financial statements as stock based compensation.  The fair value of the options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:
	Risk-free interest rate	0.45%
	Dividend yield	0.00%
	Volatility factor	271.79%
	Weighted average expected life	7 years
	In July 2013, the Company granted the CEO and four directors options to purchase an aggregate of 500,000 shares of the Company's common stock at an exercise price of $.05 per share, in exchange for unpaid services expenses.  All 500,000 options were fully vested on the grant date.  The quoted market price of the stock was $.12 per share on the grant date.  The Company valued the options at $.12 per share, or $60,000.  This amount is reflected in the accompanying financial statements as stock based compensation.  The fair value of the options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:
	Risk-free interest rate	0.59%
	Dividend yield	0.00%
	Volatility factor	314.40%
	Weighted average expected life	5 years
	In August 2012, the Company granted the VP Finance & CFO options to purchase an aggregate of 150,000 shares of the Company's common stock at an exercise price of $.05 per share, in exchange for unpaid services expenses.  All 150,000 options were fully vested on the grant date.  The quoted market price of the stock was $.12 per share on the grant date.  The Company valued the options at $.12 per share, or $18,000.  This amount is reflected in the accompanying financial statements as stock based compensation.  The fair value of the options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:
	Risk-free interest rate	0.59%
	Dividend yield	0.00%
	Volatility factor	314.40%
	Weighted average expected life	5 years

7_Income_Taxes

7. Income Taxes	12 Months Ended
	Jul. 31, 2013
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	The Company accounts for income taxes under FASB ASC Topic 740, which requires use of the liability method.  FASB ASC Topic 740 provides that deferred tax assets and liabilities are recorded based on the differences the tax basis of assets and liabilities and their carrying amounts for financial reporting purposes, referred to as temporary differences.
	As of July 31, 2013, the Company incurred a net operating loss and, accordingly, no provision for income taxes has been recorded.  In addition, no benefit for income taxes has been recorded due to the uncertainty of the realization of any tax assets.  The Company has approximately $3,267,261 and $3,297,620 of federal net operating loss carry forwards at July 31, 2013 and 2012, respectively.  The net operating loss carry forwards, if not utilized, will begin to expire in 2031.
	The Components of the Company's deferred tax asset are as follows:
		31-Dec				December 31,
		2013				2012
	Deferred tax assets:		$	3,267,261			$	3,297,620
	Net operating loss carry forwards
	Net deferred tax assets before valuation allowance		$	1,110,869			$	1,121,191
	Less:  Valuation allowance			(1,110,869	)			(1,121,191	)
	Net Deferred tax assets		$	-			$	-
	Based on the available objective evidence, including the Company's history of losses, management believes it is more likely than not, the net deferred tax assets will not be fully realizable.  Accordingly, the Company provided for a full valuation allowance against its net deferred tax assets at December 31, 2013 and 2012.  The Company had no uncertain tax positions as of December 31, 2013 and 2012.
	A reconciliation between the amounts of income tax benefit determined by applying the federal and state statutory income tax rate to pre-tax loss is as follows:
			December 31,				December 31,
			2013				2012
	Federal and state statutory rate			37.06	%			37.06	%
	Change in valuation allowance on deferred taxes			(37.06	%)			(37.06	%)

8_Commitments

8. Commitments	12 Months Ended
	Jul. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
8. Commitments	'
	Beginning February 2007, the Company commenced a month-to-month lease on a "virtual" office at a rate of $150 per month.  Rent expense for the years ended July 31, 2013 and 2012 and for the period from March 1, 2005 (inception) through July 31, 2013 totaled $1,800, $1,800 and $56,731, respectively.

9_Concentration_of_Credit_Risk

9. Concentration of Credit Risk for Cash	12 Months Ended
	Jul. 31, 2013
Risks and Uncertainties [Abstract]	'
9. Concentration of Credit Risk for Cash	'
	The Company has concentrated its credit risk for cash by maintaining deposits in a financial institution, which may at times exceed the amounts covered by insurance provided by the United States Federal Deposit Insurance Corporation ("FDIC").  At July 31, 2013 and 2012, the loss that would have resulted from that risk totaled $-0-.  The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk to cash.

10_Restatement_of_2012_Financi

10. Restatement of 2012 Financial Statements	12 Months Ended
	Jul. 31, 2013
Accounting Changes and Error Corrections [Abstract]	'
10. Restatement of 2012 Financial Statements	'
	In February 2014 the Company identified several errors in the previously issued consolidated financial statements that required restatement.  Three areas of concern were identified for adjustment:  common shares for directors' fees that should have been but were not issued in the 2012 fiscal year, the recording of Prepaid Expenses related to extension fees due to the holder of a promissory note, and the recording of the conversion feature on the Company's promissory notes where the conversion rate is below the market price of the common stock.
	CONSOLIDATED BALANCE SHEET AS OF JULY 31, 2012
			31-Jul-12
			As Previouly								As
			Reported				Adjustments				Restated
	Assets
	Current Assets:
	Cash	$		4,710		$		(1	)	$		4,709
	Prepaid expenses			3,738				(3,738	)			—
	Total current assets			8,448				(3,739	)			4,709
	Deposits			150				—				150
	Total assets	$		8,598		$		(3,739	)	$		4,859
	Liabilities and Shareholders' Deficit
	Current Liabilities:
	Accounts and notes payable:
	Accounts payable	$		80,464		$		—		$		80,464
	Accounts payable, related party			3,900				—				3,900
	Accrued compensation, related party			410,625				—				410,625
	Accrued liabilities			15,597				(2,768	)			12,829
	Accrued liabilities, related party			100,523				2,318				102,841
	Notes payable, related party, net of unamortized discount of $419			—				73,755				73,755
	Note payable, net of unamortized discount of $1,592			171,161				(75,766	)			95,395
	Total current liabilities			782,270				(2,461	)			779,809
	Shareholders' deficit:
	Preferred stock, $.001 par value; 25,000,000 shares authorized,
	1,491,743 shares issued and outstanding			1,492				—				1,492
	Common stock, $.001 par value, 33,333,333 shares authorized
	16,870,234 shares issued and outstanding			16,871				—				16,871
	Stock Payable			—				55,500				55,500
	Additional paid-in capital			6,884,345				12,110				6,896,455
	Accumulated Deficit			(7,676,380	)			(68,888	)			(7,745,268	)
	Total shareholders' deficit			(773,672	)			(1,278	)			(774,950	)
	Total liabilities and shareholders' deficit	$		8,598		$		(3,739	)	$		4,859
	CONSOLIDATED STATEMENT OF OPERATIONS FOR THE YEAR ENDING JULY 31, 2012
			July 31 2012
			As Previously								As
			Reported				Adjustments				Restated
	Sales	$		—		$		—		$		—
	Cost of sales			—				—				—
				—				—				—
	Operating expenses:
	Professional and consulting fees			155,923				50,960				206,883
	Travel			22,008				2				22,010
	Other general and administrative expenses			4,192				—				4,192
	Total operating expenses			182,123				50,962				233,085
	Loss from operations			(182,123	)			(50,962	)			(233,085	)
	Other expense:
	Interest expense			(134,918	)			20,231				(114,687	)
	Loss before income taxes			(317,041	)			(30,731	)			(347,772	)
	Income tax provision			—				—				—
	Net loss	$		(317,041	)		$	(30,731	)	$		(347,772	)
	Basic and diluted loss per share			(0.01	)							(0.01	)
	Basic and diluted weighted average
	common shares outstanding			24,985,016								24,985,016

11_Subsequent_Event

11. Subsequent Event	12 Months Ended
	Jul. 31, 2013
Subsequent Events [Abstract]	'
11. Subsequent Event	'
	In August 2013, the Company issued 503,750 shares of the Company's common stock in exchange for accrued interest and renewal of five Promissory Notes.
	In September 2013, the Company issued 167,917 additional shares of the Company's common stock in exchange for accrued interest and renewal of the five Promissory Notes noted above.
	In September 2013, the Company issued a convertible promissory note to an unrelated party in exchange for $3,000.
	In December 2013, the Company issued convertible promissory notes to related parties in exchange for $16,000.
	In October 2013, the Company was notified by Hamilton, P.C. that it had resigned as the Company's independent public accountant.
	In October 2013, the Company appointed M&K CPAS, PLLC in Houston, Texas, as the registered independent public accountant for the fiscal years ended July 31, 2013 and 2012.
	In March 2014, the Company issued 300,000 shares of common stocks to Directors as compensation for services provided.  These shares, approved August 2011, were to be issued February 2012.  The liability for this transaction had been accrued to the date granted.

1_Organization_Basis_of_Presen

1. Organization, Basis of Presentation, and Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Jul. 31, 2013
Organization Basis Of Presentation And Summary Of Significant Accounting Policies Policies	'
Organization and Basis of Presentation	'
	Worldwide Strategies Incorporated (the "Company") was originally incorporated in the state of Nevada on April 6, 1998.  On March 1, 2005, Worldwide Business Solutions Incorporated ("WBSI") was incorporated in the State of Colorado.  On July 8, 2005, the Company acquired all the shares of WBSI for 76.8% of the Company's outstanding stock.  The acquisition of WBSI has been accounted for as a recapitalization of WBSI.  Therefore the historical information prior to the date of recapitalization is the financial information of WBSI.
	Effective July 31, 2007 the Company filed a Certificate of Change Pursuant to NRS 78.209, which decreased the number of its authorized shares of common stock from 100,000,000 to 33,333,333 and reduced the number of common shares issued and outstanding from 17,768,607 to 5,923,106.
	All shares and per share amounts in these Consolidated Financial Statements and related notes have been retroactively adjusted to reflect the reverse stock split for all periods presented.
	On July 31, 2007, the Company acquired 100% of the issued and outstanding shares of Centric Rx, Inc., ("Centric") in exchange for 2,250,000 shares of the Company's common stock.  As a result of the acquisition, Centric became a wholly owned subsidiary of the Company and the results of its operation have been included in the Company's consolidated financial statements since the date of acquisition.
Development Stage	'
	In June 2014, the FASB issued ASU No. 2014-10: Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements to improve financial reporting by reducing cost and complexity associated with the incremental reporting requirements of development stage entities.  The changes eliminate the need for inception to date reporting and other disclosure requirements.  The amendments are effective for annual reporting periods beginning after December 15, 2014.  Early adoption is permitted.  The Company has elected early adoption of these amendments.
Going Concern	'
	The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States, which contemplate continuation of the Company as a going concern.  However, the Company experienced net losses of $232,681, $347,772, and $7,977,949 for the years ended July 31, 2013 and 2012 and for the period from March 1, 2005 (inception) through July 31, 2013, respectively.  In addition, the Company has incurred liabilities in excess of assets over the past year and, as of July 31, 2013, has an accumulated deficit of $7,977,949. These matters, among others, raise substantial doubt about its ability to continue as a going concern.
	In view of the matters described above, recoverability of a major portion of the recorded asset amounts shown in the accompanying balance sheet is dependent upon the Company's ability to generate sufficient sales volume to cover its operating expenses and to raise sufficient capital to meet its payment obligations.  Historically, management has been able to raise additional capital. During the year ended July 31, 2013, the Company issued convertible promissory notes in exchange for $49,550.
	The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence.
Principles of Consolidation	'
	The accompanying Consolidated Financial Statements include the Company's accounts and those of its wholly owned subsidiaries.  All significant intercompany transactions and balances have been eliminated in consolidation.
Use of Estimates	'
	The preparation of financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.
Cash and Cash Equivalents	'
	The Company considers all highly liquid debt instruments with original maturities of three months or less when acquired to be cash equivalents.  The Company had no cash equivalents at July 31, 2013 or 2012.
Financial Instruments	'
	The carrying amounts of cash and current liabilities approximate fair value due to the short-term maturity of the instruments.
Property and Equipment	'
	Property and equipment are stated at cost.  Depreciation is calculated using the straight-line method over the estimated useful lives of the related assets, currently ranging from three to five years.  Expenditures for additions and improvements are capitalized, while repairs and maintenance costs are expensed as incurred.  The cost and related accumulated depreciation of property and equipment sold or otherwise disposed of are removed from the accounts and any gain or loss is recorded in the year of disposal.
				July 31,
				2013			2012
		Office equipment		$	10,600		$	10,600
		Software			12,023			12,023
					22,623			22,623
		Accumulated depreciation			22,623			22,623
		Property and equipment - net		$	0		$	0
	Depreciation expense for the years ended July 31, 2013 and 2012 and for the period from March 1, 2005 (inception) through July 31, 2013 totaled $-0-, $-0-, and $140,278, respectively.
Impairment of Long-Lived Assets	'
	The Company has adopted ASC 360, "Accounting for the Impairment or Disposal of Long-Lived Assets," which requires that long-lived assets to be held be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  ASC 360 establishes a single auditing model for long-lived assets to be disposed of by sale.
Loss per Common Share	'
	The Company reports net loss per share using a dual presentation of basic and diluted loss per share. Basic earnings (loss) per share are computed by dividing the net income (loss) by the weighted-average number of shares of common stock and common stock equivalents (primarily outstanding options and convertible preferred stock). Common stock equivalents represent the dilutive effect of the assumed exercise of the outstanding stock options and convertible preferred stock, using the treasury stock method. The calculation of fully diluted earnings (loss) per share assumes the dilutive effect of the exercise of outstanding options and convertible preferred stock at either the beginning of the respective period presented or the date of issuance, whichever is later. At July 31, 2013 and 2012, the Company had outstanding options equivalent to 4,333,328 and 3,508,328 common shares respectively and convertible preferred stock equivalent to 9,323,400 common shares.
Stock-based Compensation	'
	The Company accounts for all stock-based payments to employees and non-employees under ASC 718 "Stock Compensation," using the fair value based method. Under the fair value method, stock-based payments are measured at the fair value of the consideration received, or the fair value of the equity instruments issued, or liabilities incurred, whichever is more reliably measurable. The cost of stock-based payments to non-employees that are fully vested and non-forfeitable at the grant date is measured and recognized at that date.
Beneficial Conversion Features	'
	From time to time, the Company may issue convertible notes that contain an imbedded beneficial conversion feature. A beneficial conversion feature exists on the date a convertible note is issued when the fair value of the underlying common stock to which the note is convertible into is in excess of the remaining unallocated proceeds of the note after first considering the allocation of a portion of the note proceeds to the fair value of warrants, if related warrants have been granted. The intrinsic value of the beneficial conversion feature is recorded as a debt discount with a corresponding amount to additional paid in capital. The debt discount is amortized to interest expense over the life of the note using the effective interest method.
Fair Value of Financial Instruments	'
	On August 1, 2012, the Company adopted ASC 820, Fair Value Measurements and Disclosures.  ASC 820 defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The three levels are defined as follows:
	Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
	Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
	Level 3 inputs to valuation methodology are unobservable and significant to the fair measurement.
	The following table represents our assets and liabilities by level measured at fair value on a recurring basis at July 31, 2013:
	Description		Level 1			Level 2		Level 3		Total
										Realized
										Loss
		$	-		$	-	$	-	$	-
	Totals	$	-		$	-	$	-	$	-
Fiscal Year-end	'
	The Company's year-end is July 31.
New Accounting Pronouncements	'
	In June 2014, the FASB issued ASU 2014-10, Development Stage Entities. The amendments in this update remove the definition of a development stage entity from the Master Glossary of the ASC thereby removing the financial reporting distinction between development stage entities and other reporting entities from U.S. GAAP. In addition, the amendments eliminate the requirements for development stage entities to (1) present inception-to-date information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. The amendments in this update are applied retrospectively. The adoption of ASU 2014-10 removed the development stage entity financial reporting requirements from the Company.
	In July 2013, the FASB issued ASU No. 2013-11: Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carry forward, a Similar Tax Loss, or a Tax Credit Carry forward Exists. The new guidance requires that unrecognized tax benefits be presented on a net basis with the deferred tax assets for such carry forwards. This new guidance is effective for fiscal years and interim periods within those years beginning after December 15, 2013. We do not expect the adoption of the new provisions to have a material impact on our financial condition or results of operations.
	In February 2013, the FASB issued ASU No. 2013-02, Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, to improve the transparency of reporting these reclassifications. Other comprehensive income includes gains and losses that are initially excluded from net income for an accounting period. Those gains and losses are later reclassified out of accumulated other comprehensive income into net income. The amendments in the ASU do not change the current requirements for reporting net income or other comprehensive income in financial statements. All of the information that this ASU requires already is required to be disclosed elsewhere in the financial statements under U.S. GAAP. The new amendments will require an organization to:
	Present (either on the face of the statement where net income is presented or in the notes) the effects on the line items of net income of significant amounts reclassified out of accumulated other comprehensive income - but only if the item reclassified is required under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period; and
	Cross-reference to other disclosures currently required under U.S. GAAP for other reclassification items (that are not required under U.S. GAAP) to be reclassified directly to net income in their entirety in the same reporting period. This would be the case when a portion of the amount reclassified out of accumulated other comprehensive income is initially transferred to a balance sheet account (e.g., inventory for pension-related amounts) instead of directly to income or expense.
	The amendments apply to all public and private companies that report items of other comprehensive income. Public companies are required to comply with these amendments for all reporting periods (interim and annual). The amendments were effective for reporting periods beginning after December 15, 2012, for public companies. Early adoption was permitted. The adoption of ASU No. 2013-02 did not have a material impact on our financial position or results of operations.
	In January 2013, the FASB issued ASU No. 2013-01, Balance Sheet (Topic 210): Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities, which clarifies which instruments and transactions are subject to the offsetting disclosure requirements originally established by ASU 2011-11. The new ASU addresses preparer concerns that the scope of the disclosure requirements under ASU 2011-11 was overly broad and imposed unintended costs that were not commensurate with estimated benefits to financial statement users. In choosing to narrow the scope of the offsetting disclosures, the Board determined that it could make them more operable and cost effective for preparers while still giving financial statement users sufficient information to analyze the most significant presentation differences between financial statements prepared in accordance with U.S. GAAP and those prepared under IFRSs. Like ASU 2011-11, the amendments in this update were effective for fiscal periods beginning on, or after January 1, 2013. The adoption of ASU 2013-01 did not have a material impact on our financial position or results of operations.
	In October 2012, the FASB issued ASU 2012-04, Technical Corrections and Improvements. The amendments in this update cover a wide range of Topics in the Accounting Standards Codification. These amendments include technical corrections and improvements to the Accounting Standards Codification and conforming amendments related to fair value measurements. The amendments in this update were effective for fiscal periods beginning after December 15, 2012. The adoption of ASU 2012-04 did not have a material impact on our financial position or results of operations.
	In August 2012, the FASB issued ASU 2012-03, Technical Amendments and Corrections to SEC Sections: Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin (SAB) No. 114, Technical Amendments Pursuant to SEC Release No. 33-9250, and Corrections Related to FASB Accounting Standards Update 2010-22 (SEC Update). This update amends various SEC paragraphs pursuant to the issuance of SAB No. 114. The adoption of ASU 2012-03 did not have a material impact on our financial position or results of operations.
	In July 2012, the FASB issued ASU 2012-02, Intangibles – Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment. This update amends ASU 2011-08, Intangibles – Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment and permits an entity first to assess
	qualitative factors to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired as a basis for determining whether it is necessary to perform the quantitative impairment test in accordance with Subtopic 350-30, Intangibles - Goodwill and Other - General Intangibles Other than Goodwill. The amendments were effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. Early adoption was permitted, including for annual and interim impairment tests performed as of a date before July 27, 2012, if a public entity's financial statements for the most recent annual or interim period have not yet been issued or, for nonpublic entities, had not yet been made available for issuance. The adoption of ASU 2012-02 did not have a material impact on our financial position or results of operations.

6_Shareholders_Deficit_Tables

6. Shareholders' Deficit (Tables)	12 Months Ended
	Jul. 31, 2013
Shareholders Deficit Tables	'
Schedule of fair value of options	'
	Risk-free interest rate	0.90%
	Dividend yield	0.00%
	Volatility factor	302.56%
	Weighted average expected life	5 years
	Risk-free interest rate	0.90%
	Dividend yield	0.00%
	Volatility factor	281.50%
	Weighted average expected life	5 years
	Risk-free interest rate	0.63%
	Dividend yield	0.00%
	Volatility factor	273.47%
	Weighted average expected life	7 years
	Risk-free interest rate	0.45%
	Dividend yield	0.00%
	Volatility factor	271.79%
	Weighted average expected life	7 years
	Risk-free interest rate	0.59%
	Dividend yield	0.00%
	Volatility factor	314.40%
	Weighted average expected life	5 years
	Risk-free interest rate	0.59%
	Dividend yield	0.00%
	Volatility factor	314.40%
	Weighted average expected life	5 years

7_Income_Taxes_Tables

7. Income Taxes (Tables)	12 Months Ended
	Jul. 31, 2013
Income Taxes Tables	'
Schedule of deferred tax asset	'
		31-Dec				December 31,
		2013				2012
	Deferred tax assets:		$	3,267,261			$	3,297,620
	Net operating loss carry forwards
	Net deferred tax assets before valuation allowance		$	1,110,869			$	1,121,191
	Less:  Valuation allowance			(1,110,869	)			(1,121,191	)
	Net Deferred tax assets		$	-			$	-
Schedule of federal income tax rate	'
			December 31,				December 31,
			2013				2012
	Federal and state statutory rate			37.06	%			37.06	%
	Change in valuation allowance on deferred taxes			(37.06	%)			(37.06	%)

10_Restatement_of_2012_Financi1

10. Restatement of 2012 Financial Statements (Tables)	12 Months Ended
	Jul. 31, 2013
Accounting Changes and Error Corrections [Abstract]	'
Schedule of restatements	'
	CONSOLIDATED BALANCE SHEET AS OF JULY 31, 2012
			31-Jul-12
			As Previouly								As
			Reported				Adjustments				Restated
	Assets
	Current Assets:
	Cash	$		4,710		$		(1	)	$		4,709
	Prepaid expenses			3,738				(3,738	)			—
	Total current assets			8,448				(3,739	)			4,709
	Deposits			150				—				150
	Total assets	$		8,598		$		(3,739	)	$		4,859
	Liabilities and Shareholders' Deficit
	Current Liabilities:
	Accounts and notes payable:
	Accounts payable	$		80,464		$		—		$		80,464
	Accounts payable, related party			3,900				—				3,900
	Accrued compensation, related party			410,625				—				410,625
	Accrued liabilities			15,597				(2,768	)			12,829
	Accrued liabilities, related party			100,523				2,318				102,841
	Notes payable, related party, net of unamortized discount of $419			—				73,755				73,755
	Note payable, net of unamortized discount of $1,592			171,161				(75,766	)			95,395
	Total current liabilities			782,270				(2,461	)			779,809
	Shareholders' deficit:
	Preferred stock, $.001 par value; 25,000,000 shares authorized,
	1,491,743 shares issued and outstanding			1,492				—				1,492
	Common stock, $.001 par value, 33,333,333 shares authorized
	16,870,234 shares issued and outstanding			16,871				—				16,871
	Stock Payable			—				55,500				55,500
	Additional paid-in capital			6,884,345				12,110				6,896,455
	Accumulated Deficit			(7,676,380	)			(68,888	)			(7,745,268	)
	Total shareholders' deficit			(773,672	)			(1,278	)			(774,950	)
	Total liabilities and shareholders' deficit	$		8,598		$		(3,739	)	$		4,859
	CONSOLIDATED STATEMENT OF OPERATIONS FOR THE YEAR ENDING JULY 31, 2012
			July 31 2012
			As Previously								As
			Reported				Adjustments				Restated
	Sales	$		—		$		—		$		—
	Cost of sales			—				—				—
				—				—				—
	Operating expenses:
	Professional and consulting fees			155,923				50,960				206,883
	Travel			22,008				2				22,010
	Other general and administrative expenses			4,192				—				4,192
	Total operating expenses			182,123				50,962				233,085
	Loss from operations			(182,123	)			(50,962	)			(233,085	)
	Other expense:
	Interest expense			(134,918	)			20,231				(114,687	)
	Loss before income taxes			(317,041	)			(30,731	)			(347,772	)
	Income tax provision			—				—				—
	Net loss	$		(317,041	)		$	(30,731	)	$		(347,772	)
	Basic and diluted loss per share			(0.01	)							(0.01	)
	Basic and diluted weighted average
	common shares outstanding			24,985,016								24,985,016

1_Organization_Basis_of_Presen1

1. Organization, Basis of Presentation, and Summary of Significant Accounting Policies (Details) (USD $)	Jul. 31, 2013	Jul. 31, 2012
Organization Basis Of Presentation And Summary Of Significant Accounting Policies Details	'	'
Office equipment	$10,600	$10,600
Software	12,023	12,023
Property and equipment, Gross	22,623	22,623
Accumulated depreciation	22,623	22,623
Property and equipment - net	$0	$0	[1]
[1]	Restated

1_Organization_Basis_of_Presen2

1. Organization, Basis of Presentation, and Summary of Significant Accounting Policies (Details Narrative) (USD $)	12 Months Ended			98 Months Ended
	Jul. 31, 2013	Jul. 31, 2012		Jul. 31, 2013
Organization Basis Of Presentation And Summary Of Significant Accounting Policies Details	'	'		'
Net loss	$232,681	$347,772	[1]	'
Accumulated deficit	-7,977,949	-7,745,268	[1]	-7,977,949
Depreciation expense	$0	$0		$140,278
[1]	Restated

2_Accounts_payable_related_par1

2. Accounts payable related parties (Details Narrative) (USD $)	Jul. 31, 2013	Jul. 31, 2012
Accounts Payable Related Parties [Text Block]	'	'
Accounts payable related parties	$3,900	$3,900

3_Accrued_compensation_Details

3. Accrued compensation (Details Narrative) (USD $)	Jul. 31, 2013	Jul. 31, 2012
Cash Paid [Abstract]	'	'
Accrued compensation	$0	$410,625

6_Shareholders_Equity_Details

6. Shareholders' Equity (Details)	12 Months Ended
	Jul. 31, 2013
Options granted the VP Finance & CFO November 2011	'
Risk-free interest rate	0.90%
Dividend yield	0.00%
Volatility factor	302.56%
Weighted average expected life	'5 years
Options granted the VP Finance & CFO March 2012	'
Risk-free interest rate	0.90%
Dividend yield	0.00%
Volatility factor	281.50%
Weighted average expected life	'5 years
Options granted two officers and four directors	'
Risk-free interest rate	0.63%
Dividend yield	0.00%
Volatility factor	273.47%
Weighted average expected life	'7 years
Options granted the VP Finance & CFO August 2012	'
Risk-free interest rate	0.45%
Dividend yield	0.00%
Volatility factor	271.79%
Weighted average expected life	'7 years
Options granted the CEO and four directors	'
Risk-free interest rate	0.59%
Dividend yield	0.00%
Volatility factor	314.40%
Weighted average expected life	'5 years
Options granted the VP Finance & CFO Second August 2012	'
Risk-free interest rate	0.59%
Dividend yield	0.00%
Volatility factor	314.40%
Weighted average expected life	'5 years

7_Income_Taxes_Details

7. Income Taxes (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Deferred tax assets:	'	'
Net operating loss carry forwards	$3,267,261	$3,297,620
Net deferred tax assets before valuation allowance	1,110,869	1,121,191
Less:B Valuation allowance	-1,110,869	-1,121,191
Net Deferred tax assets	$0	$0

7_Income_Taxes_Details_1

7. Income Taxes (Details 1)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Income Taxes Details	'	'
U.S. statutory federal rate, graduated	37.06%	37.06%
Change in valuation allowance on deferred taxes	-37.06%	-37.06%

8_Commitments_Details_Narrativ

8. Commitments (Details Narrative) (USD $)	12 Months Ended		98 Months Ended
	Jul. 31, 2013	Jul. 31, 2012	Jul. 31, 2013
Payments For Offering Costs	'	'	'
Rent Expense	$1,800	$1,800	$56,731

10_Restatement_of_2012_Financi2

10. Restatement of 2012 Financial Statements (Details) (USD $)	Jul. 31, 2013	Jul. 31, 2012		Jul. 31, 2011
Current Assets:	'	'		'
Total current assets	$3,537	$4,709	[1]	'
Total assets	3,687	4,859	[1]	'
Liabilities and Shareholders' Deficit	'	'		'
Accounts payable	84,846	80,464	[1]	'
Accounts payable, related party	3,900	3,900	[1]	'
Accrued liabilities	26,503	12,829	[1]	'
Notes payable, related party, net of unamortized discount of $419	76,445	73,755	[1]	'
Note payable, net of unamortized discount of $1,592	135,300	95,395	[1]	'
Total current liabilities	331,717	779,809	[1]	'
Shareholders' deficit:	'	'		'
Preferred stock, $.001 par value; 25,000,000 shares authorized, 1,491,743 shares issued and outstanding	1,492	1,492	[1]	'
Common stock, $.001 par value, 33,333,333 shares authorized 16,870,234 shares issued and outstanding	18,860	16,871	[1]	'
Stock Payable	54,000	55,500	[1]	'
Additional paid-in capital	7,575,567	6,896,455	[1]	'
Accumulated Deficit	-7,977,949	-7,745,268	[1]	'
Total shareholders' deficit	-328,030	-774,950	[1]	-671,938
Total liabilities and shareholders' deficit	3,687	4,859	[1]	'
As previously reported	'	'		'
Current Assets:	'	'		'
Cash	'	4,710		'
Prepaid expenses	'	3,738		'
Total current assets	'	8,448		'
Deposits	'	150		'
Total assets	'	8,598		'
Liabilities and Shareholders' Deficit	'	'		'
Accounts payable	'	80,464		'
Accounts payable, related party	'	3,900		'
Accrued compensation, related party	'	410,625		'
Accrued liabilities	'	15,597		'
Accrued liabilities, related party	'	100,523		'
Notes payable, related party, net of unamortized discount of $419	'	0		'
Note payable, net of unamortized discount of $1,592	'	171,161		'
Total current liabilities	'	782,270		'
Shareholders' deficit:	'	'		'
Preferred stock, $.001 par value; 25,000,000 shares authorized, 1,491,743 shares issued and outstanding	'	1,492		'
Common stock, $.001 par value, 33,333,333 shares authorized 16,870,234 shares issued and outstanding	'	16,871		'
Stock Payable	'	0		'
Additional paid-in capital	'	6,884,345		'
Accumulated Deficit	'	-7,676,380		'
Total shareholders' deficit	'	-773,672		'
Total liabilities and shareholders' deficit	'	8,598		'
Adjustments	'	'		'
Current Assets:	'	'		'
Cash	'	-1		'
Prepaid expenses	'	-3,738		'
Total current assets	'	-3,739		'
Deposits	'	0		'
Total assets	'	-3,739		'
Liabilities and Shareholders' Deficit	'	'		'
Accounts payable	'	0		'
Accounts payable, related party	'	0		'
Accrued compensation, related party	'	0		'
Accrued liabilities	'	-2,768		'
Accrued liabilities, related party	'	2,318		'
Notes payable, related party, net of unamortized discount of $419	'	73,755		'
Note payable, net of unamortized discount of $1,592	'	-75,766		'
Total current liabilities	'	-2,461		'
Shareholders' deficit:	'	'		'
Preferred stock, $.001 par value; 25,000,000 shares authorized, 1,491,743 shares issued and outstanding	'	0		'
Common stock, $.001 par value, 33,333,333 shares authorized 16,870,234 shares issued and outstanding	'	0		'
Stock Payable	'	55,500		'
Additional paid-in capital	'	12,110		'
Accumulated Deficit	'	-68,888		'
Total shareholders' deficit	'	-1,278		'
Total liabilities and shareholders' deficit	'	-3,739		'
As reported	'	'		'
Current Assets:	'	'		'
Cash	'	4,709		'
Prepaid expenses	'	0		'
Total current assets	'	4,709		'
Deposits	'	150		'
Total assets	'	4,859		'
Liabilities and Shareholders' Deficit	'	'		'
Accounts payable	'	80,464		'
Accounts payable, related party	'	3,900		'
Accrued compensation, related party	'	410,625		'
Accrued liabilities	'	12,829		'
Accrued liabilities, related party	'	102,841		'
Notes payable, related party, net of unamortized discount of $419	'	73,755		'
Note payable, net of unamortized discount of $1,592	'	95,395		'
Total current liabilities	'	779,809		'
Shareholders' deficit:	'	'		'
Preferred stock, $.001 par value; 25,000,000 shares authorized, 1,491,743 shares issued and outstanding	'	1,492		'
Common stock, $.001 par value, 33,333,333 shares authorized 16,870,234 shares issued and outstanding	'	16,871		'
Stock Payable	'	55,500		'
Additional paid-in capital	'	6,896,455		'
Accumulated Deficit	'	-7,745,268		'
Total shareholders' deficit	'	-774,950		'
Total liabilities and shareholders' deficit	'	$4,859		'
[1]	Restated

10_Restatement_of_2012_Financi3

10. Restatement of 2012 Financial Statements (Details 1) (USD $)	12 Months Ended
	Jul. 31, 2013	Jul. 31, 2012
Gross Profit	$0	$0	[1]
Operating expenses:	'	'
Other general and administrative expenses	3,784	4,192	[1]
Total operating expenses	154,506	233,085	[1]
Loss from operations	-154,506	-233,085	[1]
Other expense:	'	'
Interest expense	-78,175	-114,687	[1]
Loss before income taxes	-232,681	-347,772	[1]
Income tax provision	0	0	[1]
Net loss	-232,681	-347,772	[1]
Basic and diluted loss per share	($0.01)	($0.01)	[1]
Basic and diluted weighted average common shares outstanding	27,487,506	24,985,016	[1]
As previously reported	'	'
Sales	'	0
Cost of sales	'	0
Gross Profit	'	0
Operating expenses:	'	'
Professional and consulting fees	'	155,923
Travel	'	22,008
Other general and administrative expenses	'	4,192
Total operating expenses	'	182,123
Loss from operations	'	-182,123
Other expense:	'	'
Interest expense	'	-134,918
Loss before income taxes	'	-317,041
Income tax provision	'	0
Net loss	'	-317,041
Basic and diluted loss per share	'	($0.01)
Basic and diluted weighted average common shares outstanding	'	24,985,016
Adjustments	'	'
Sales	'	0
Cost of sales	'	0
Gross Profit	'	0
Operating expenses:	'	'
Professional and consulting fees	'	50,960
Travel	'	2
Other general and administrative expenses	'	0
Total operating expenses	'	50,962
Loss from operations	'	-50,962
Other expense:	'	'
Interest expense	'	20,231
Loss before income taxes	'	-30,731
Income tax provision	'	0
Net loss	'	-30,731
As reported	'	'
Sales	'	0
Cost of sales	'	0
Gross Profit	'	0
Operating expenses:	'	'
Professional and consulting fees	'	206,883
Travel	'	22,010
Other general and administrative expenses	'	4,192
Total operating expenses	'	233,085
Loss from operations	'	-233,085
Other expense:	'	'
Interest expense	'	-114,687
Loss before income taxes	'	-347,772
Income tax provision	'	0
Net loss	'	($347,772)
Basic and diluted loss per share	'	($0.01)
Basic and diluted weighted average common shares outstanding	'	24,985,016
[1]	Restated